FibroBox: a novel noninvasive tool for predicting significant liver fibrosis and cirrhosis in HBV infected patients
Abstract Background China is a highly endemic area of chronic hepatitis B (CHB). The accuracy of existed noninvasive biomarkers including TE, APRI and FIB-4 for staging fibrosis is not high enough in Chinese cohort. Methods Using liver biopsy as a gold standard, a novel noninvasive indicator was dev...
Main Authors: | Xiao-Jie Lu, Xiao-Jun Yang, Jing-Yu Sun, Xin Zhang, Zhao-Xin Yuan, Xiu-Hui Li |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2020-09-01
|
Series: | Biomarker Research |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40364-020-00215-2 |
Similar Items
-
Noninvasive diagnosis of liver fibrosis in patients with nonalcoholic fatty liver disease
by: Yu.M. Stepanov, et al.
Published: (2017-09-01) -
Correlation between HBV-DNA levels and liver fibrosis in patients with chronic hepatitis B
by: Bao-Jun Li, et al.
Published: (2016-02-01) -
Notum attenuates HBV-related liver fibrosis through inhibiting Wnt 5a mediated non-canonical pathways
by: Wenting Li, et al.
Published: (2019-03-01) -
The role of noninvasive biomarkers in diagnosis and risk stratification in nonalcoholic fatty liver disease
by: Jose Hernandez Roman, et al.
Published: (2020-10-01) -
Noninvasive assessment of liver fibrosis: Serum markers and transient elastography (FibroScan) Evaluación no invasiva de fibrosis hepática: Marcadores séricos y elastografía transitoria (FibroScan)
by: J. C. Marín-Gabriel, et al.
Published: (2009-11-01)